2024
An update on the management of axial spondyloarthritis for sports medicine professionals
Danve A, Magrey M, Deodhar A. An update on the management of axial spondyloarthritis for sports medicine professionals. BMC Sports Science, Medicine And Rehabilitation 2024, 16: 211. PMID: 39375817, PMCID: PMC11460014, DOI: 10.1186/s13102-024-00998-z.Peer-Reviewed Original ResearchNonsteroidal anti-inflammatory drugsBiologic disease-modifying antirheumatic drugsMedicine practitionersImprove health-related quality of lifeSuspected axSpAHealth-related quality of lifeImprove health-related qualitySports medicine professionalsSports medicine practitionersChronic back painManagement of axial spondyloarthritisReferral of patientsDisease-modifying antirheumatic drugsCurrent treatment possibilitiesInadequately controlled diseaseQuality of lifeTargeted synthetic (ts) DMARDsFirst-line treatmentHeterogeneous clinical featuresLong-term outcomesDisease activity measuresPhysical therapyBack painChronic inflammatory diseaseMedicine professionals
2015
The ongoing quest for biomarkers in Ankylosing Spondylitis
Danve A, O'Dell J. The ongoing quest for biomarkers in Ankylosing Spondylitis. International Journal Of Rheumatic Diseases 2015, 18: 826-834. PMID: 26469363, DOI: 10.1111/1756-185x.12779.Peer-Reviewed Original ResearchConceptsRadiographic progressionC-reactive proteinChronic inflammatory diseaseQuality of lifeDisease activityPotential clinical applicationsHLA-B27Ankylosing SpondylitisDiscovery of biomarkersInflammatory diseasesEarly diagnosisNew biomarkersSpondylitisBiomarkersDisease assessmentClinical applicationProgressionImmunopathogenesisTherapySymptomsDiseaseDiagnosis